KR900003095B1 - 신규 thf 조성물의 제조방법 - Google Patents

신규 thf 조성물의 제조방법 Download PDF

Info

Publication number
KR900003095B1
KR900003095B1 KR1019860004468A KR860004468A KR900003095B1 KR 900003095 B1 KR900003095 B1 KR 900003095B1 KR 1019860004468 A KR1019860004468 A KR 1019860004468A KR 860004468 A KR860004468 A KR 860004468A KR 900003095 B1 KR900003095 B1 KR 900003095B1
Authority
KR
South Korea
Prior art keywords
thf
aliquots
leu
amino acid
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019860004468A
Other languages
English (en)
Korean (ko)
Other versions
KR870000357A (ko
Inventor
트레이닌 네이산
버어스타인 이걸
Original Assignee
에다 리서어치 앤드 디 베롭프멘트 캄파니 리미팃드
아이작 티이 콜버그, 윌리엄 타웁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에다 리서어치 앤드 디 베롭프멘트 캄파니 리미팃드, 아이작 티이 콜버그, 윌리엄 타웁 filed Critical 에다 리서어치 앤드 디 베롭프멘트 캄파니 리미팃드
Publication of KR870000357A publication Critical patent/KR870000357A/ko
Application granted granted Critical
Publication of KR900003095B1 publication Critical patent/KR900003095B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/065—Thymic humoral factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/18—Thymus derived hormone or factor; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019860004468A 1985-06-06 1986-06-05 신규 thf 조성물의 제조방법 Expired KR900003095B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US741753 1985-06-06
US06/741,753 US4621135A (en) 1983-12-08 1985-06-06 Novel THF compositions
US741.753 1985-06-06

Publications (2)

Publication Number Publication Date
KR870000357A KR870000357A (ko) 1987-02-18
KR900003095B1 true KR900003095B1 (ko) 1990-05-07

Family

ID=24982034

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860004468A Expired KR900003095B1 (ko) 1985-06-06 1986-06-05 신규 thf 조성물의 제조방법

Country Status (16)

Country Link
US (1) US4621135A (enExample)
EP (1) EP0204328B1 (enExample)
JP (2) JPS6248698A (enExample)
KR (1) KR900003095B1 (enExample)
AT (1) ATE110389T1 (enExample)
AU (1) AU569193B2 (enExample)
CA (1) CA1270597A (enExample)
CZ (1) CZ419491A3 (enExample)
DE (2) DE3650035T2 (enExample)
DK (1) DK262986A (enExample)
ES (6) ES8801322A1 (enExample)
HK (1) HK195495A (enExample)
IL (1) IL78951A (enExample)
NZ (1) NZ216316A (enExample)
SK (1) SK419491A3 (enExample)
ZA (1) ZA863848B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US6066622A (en) * 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
MX339762B (es) * 2011-09-28 2016-05-27 Univ Autonoma Del Estado De Morelos Metalopeptidos inmunomoduladores (immp) y composiciones que los contienen.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4881838A (enExample) * 1972-02-15 1973-11-01
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
NL7502830A (nl) * 1974-03-25 1975-09-29 Jean Francois Bach En Dr Jean Werkwijze voor het isoleren van een polypeptide hormoon.
IL47645A (en) * 1975-07-04 1980-10-26 Yeda Res & Dev Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it
DE2732587A1 (de) * 1976-09-22 1978-03-23 Bach Jean Francois Polypeptid mit thymischer wirksamkeit
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
US4275153A (en) * 1978-08-03 1981-06-23 American Hospital Supply Corporation Analytical fluorogenic substrates for proteolytic enzymes
SE448605B (sv) * 1980-10-27 1987-03-09 Vtoroi Mo G Med I Imen Terapeutiskt preparat for reglering av t-immunsystemet och forfarande for framstellning derav
US4374828A (en) * 1980-11-17 1983-02-22 Board Of Reagents, The University Of Texas System Biologically active thymones from the thymus
IT1148005B (it) * 1981-04-09 1986-11-26 Leonida Grippa Tripeptide nelle sue sei combinazioni amminoacide alania fenilalanina e leucina in particolare fenil-alanina-alanina-leucina (p-a-l) aventela proprieta' di esaltare l'immunita' antivirale ed antitumorale
US4505898A (en) * 1982-04-21 1985-03-19 Marks Robert E Derivatives of acetylsalicylic acid and substituted phenylacetic acids and compositions containing them

Also Published As

Publication number Publication date
DK262986D0 (da) 1986-06-04
ES8801315A1 (es) 1987-12-16
AU5833686A (en) 1987-01-08
JPH01156997A (ja) 1989-06-20
ES555737A0 (es) 1987-12-16
NZ216316A (en) 1991-11-26
JPS6248698A (ja) 1987-03-03
EP0204328A2 (en) 1986-12-10
DE3650035D1 (de) 1994-09-29
DK262986A (da) 1986-12-07
AU569193B2 (en) 1988-01-21
KR870000357A (ko) 1987-02-18
EP0204328B1 (en) 1994-08-24
ES557737A0 (es) 1987-12-16
HK195495A (en) 1996-01-05
ZA863848B (en) 1987-12-30
IL78951A (en) 1990-11-05
CZ419491A3 (en) 1993-03-17
ES557736A0 (es) 1987-12-16
DE204328T1 (de) 1987-11-05
EP0204328A3 (en) 1988-07-27
ES557739A0 (es) 1988-01-01
ES557738A0 (es) 1987-12-16
ES8801322A1 (es) 1987-12-16
IL78951A0 (en) 1986-09-30
DE3650035T2 (de) 1995-03-23
SK419491A3 (en) 1995-07-11
ES8801316A1 (es) 1987-12-16
ES8801307A1 (es) 1987-12-16
ATE110389T1 (de) 1994-09-15
CA1270597A (en) 1990-06-19
ES8801308A1 (es) 1987-12-16
ES557740A0 (es) 1987-12-16
ES8801317A1 (es) 1988-01-01
JPH0422919B2 (enExample) 1992-04-20
US4621135A (en) 1986-11-04
JPH0210160B2 (enExample) 1990-03-06

Similar Documents

Publication Publication Date Title
Audhya et al. Complete amino acid sequences of bovine thymopoietins I, II, and III: closely homologous polypeptides
CA1241597A (en) Human lymphotoxin
JPH03504013A (ja) Ｔ細胞ヘルパー活性を有するペプチド
van der Rest et al. A comprehensive approach to the study of collagen primary structure based on high‐performance liquid chromatography
JPS61118400A (ja) 成長ホルモン放出性因子類似体及びその製造方法
Dotimas et al. Isolation and structure analysis of bee venom mast cell degranulating peptide
KR900003095B1 (ko) 신규 thf 조성물의 제조방법
Rosenstreich et al. A human urine-derived interleukin 1 inhibitor. Homology with deoxyribonuclease I.
WO1996039428A1 (en) Antitumor proteins from rana pipiens oocytes
EP0087066B1 (en) Process for purifying secretin
Albericio et al. Convergent solid phase peptide synthesis. v. synthesis of the 1-4, 32-34, and 53-59 protected segments of the toxin ii of androctonus australis hector.
Hashim et al. Experimental allergic encephalomyelitis: Basic protein regions responsible for delayed hypersensitivity
Rosmus et al. Studies on the structure of collagen: I. The sequence analysis of peptides released by pronase
CA1234565A (en) Heptadecapeptide
EP0226158B1 (en) Peptides correlated to lysozyme
US4430264A (en) Process for the preparation of a selective anorexogenic substance regulating food intake
Low et al. Isolation and structural studies of porcine, ovine and murine thymosin β4 by high-performance liquid chromatography
JP3734855B2 (ja) ペプチド及びその用途
JP2793216B2 (ja) 粘膜による吸収を高める、ソルビン及び誘導ペプチド
Atherton OCH2CO. Gly. OCH2
JP4171794B2 (ja) ペプチド及びその用途
JPH01503038A (ja) ガンマインターフェロン活性を有する新規ポリペプチド
Franek et al. Selective isolation of large half-cystine—containing peptides Amino acid sequence near some half-cystines in porcine immunoglobulin γ-chains
Abiko et al. Syntheses of two deacetyl‐thymosin α1 analogues and their effects on low E‐rosette‐forming lymphocytes of uraemic patients
JPS63139197A (ja) 大腸菌外膜蛋白関連ペプチド

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 19970722

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19980508

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19980508

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000